Cargando…

Validation of the German version of the STarT-MSK-Tool: A cohort study with patients from physiotherapy clinics

BACKGROUND: The STarT-MSK-Tool is an adaptation of the well established STarT-Back-Tool, used to risk-stratify patients with a wider range of musculoskeletal presentations. OBJECTIVE: To formally translate and cross-culturally adapt the Keele STarT-MSK risk stratification tool into German (STarT-MSK...

Descripción completa

Detalles Bibliográficos
Autores principales: Karstens, Sven, Zebisch, Jochen, Wey, Johannes, Hilfiker, Roger, Hill, Jonathan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249194/
https://www.ncbi.nlm.nih.gov/pubmed/35776764
http://dx.doi.org/10.1371/journal.pone.0269694
_version_ 1784739523962339328
author Karstens, Sven
Zebisch, Jochen
Wey, Johannes
Hilfiker, Roger
Hill, Jonathan C.
author_facet Karstens, Sven
Zebisch, Jochen
Wey, Johannes
Hilfiker, Roger
Hill, Jonathan C.
author_sort Karstens, Sven
collection PubMed
description BACKGROUND: The STarT-MSK-Tool is an adaptation of the well established STarT-Back-Tool, used to risk-stratify patients with a wider range of musculoskeletal presentations. OBJECTIVE: To formally translate and cross-culturally adapt the Keele STarT-MSK risk stratification tool into German (STarT-MSK(G)) and to establish its reliability and validity. METHODS: A formal, multi-step, forward and backward translation approach was used. To assess validity patients aged ≥18 years, with acute, subacute or chronic musculoskeletal presentations in the lumbar spine, hip, knee, shoulder, or neck were included. The prospective cohort was used with initial data collected electronically at the point-of-consultation. Retest and 6-month follow-up questionnaires were sent by email. Test-retest reliability, construct validity, discriminative ability, predictive ability and floor or ceiling effects were analysed using intraclass correlation coefficient, and comparisons with a reference standard (Orebro-Musculoskeletal-Pain-Questionnaire: OMPQ) using correlations, ROC-curves and regression models. RESULTS: The participants’ (n = 287) mean age was 47 (SD = 15.8) years, 51% were female, with 48.8% at low, 43.6% at medium, and 7.7% at high risk. With ICC = 0.75 (95% CI 0.69; 0.81) test-retest-reliability was good. Construct validity was good with correlations for the STarT-MSK(G)-Tool against the OMPQ-Tool of r(s) = 0.74 (95% CI 0.68, 0.79). The ability of the tool [comparison OMPQ] to predict 6-month pain and disability was acceptable with AUC = 0.77 (95% CI 0.71, 0.83) [OMPQ = 0.74] and 0.76 (95% CI 0.69, 0.82) [OMPQ = 0.72] respectively. However, the explained variance (linear/logistic regression) for predicting 6-month pain (21% [OMPQ = 17%]/logistic = 29%) and disability (linear = 20%:[OMPQ = 19%]/logistic = 26%), whilst being comparable to the existing OMPQ reference standard, fell short of the a priori target of ≥30%. CONCLUSIONS: The German version of the STarT-MSK-Tool is a valid instrument for use across multiple musculoskeletal conditions and is availabe for use in clinical practice. Comparison with the OMPQ suggests it is a good alternative.
format Online
Article
Text
id pubmed-9249194
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-92491942022-07-02 Validation of the German version of the STarT-MSK-Tool: A cohort study with patients from physiotherapy clinics Karstens, Sven Zebisch, Jochen Wey, Johannes Hilfiker, Roger Hill, Jonathan C. PLoS One Research Article BACKGROUND: The STarT-MSK-Tool is an adaptation of the well established STarT-Back-Tool, used to risk-stratify patients with a wider range of musculoskeletal presentations. OBJECTIVE: To formally translate and cross-culturally adapt the Keele STarT-MSK risk stratification tool into German (STarT-MSK(G)) and to establish its reliability and validity. METHODS: A formal, multi-step, forward and backward translation approach was used. To assess validity patients aged ≥18 years, with acute, subacute or chronic musculoskeletal presentations in the lumbar spine, hip, knee, shoulder, or neck were included. The prospective cohort was used with initial data collected electronically at the point-of-consultation. Retest and 6-month follow-up questionnaires were sent by email. Test-retest reliability, construct validity, discriminative ability, predictive ability and floor or ceiling effects were analysed using intraclass correlation coefficient, and comparisons with a reference standard (Orebro-Musculoskeletal-Pain-Questionnaire: OMPQ) using correlations, ROC-curves and regression models. RESULTS: The participants’ (n = 287) mean age was 47 (SD = 15.8) years, 51% were female, with 48.8% at low, 43.6% at medium, and 7.7% at high risk. With ICC = 0.75 (95% CI 0.69; 0.81) test-retest-reliability was good. Construct validity was good with correlations for the STarT-MSK(G)-Tool against the OMPQ-Tool of r(s) = 0.74 (95% CI 0.68, 0.79). The ability of the tool [comparison OMPQ] to predict 6-month pain and disability was acceptable with AUC = 0.77 (95% CI 0.71, 0.83) [OMPQ = 0.74] and 0.76 (95% CI 0.69, 0.82) [OMPQ = 0.72] respectively. However, the explained variance (linear/logistic regression) for predicting 6-month pain (21% [OMPQ = 17%]/logistic = 29%) and disability (linear = 20%:[OMPQ = 19%]/logistic = 26%), whilst being comparable to the existing OMPQ reference standard, fell short of the a priori target of ≥30%. CONCLUSIONS: The German version of the STarT-MSK-Tool is a valid instrument for use across multiple musculoskeletal conditions and is availabe for use in clinical practice. Comparison with the OMPQ suggests it is a good alternative. Public Library of Science 2022-07-01 /pmc/articles/PMC9249194/ /pubmed/35776764 http://dx.doi.org/10.1371/journal.pone.0269694 Text en © 2022 Karstens et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Karstens, Sven
Zebisch, Jochen
Wey, Johannes
Hilfiker, Roger
Hill, Jonathan C.
Validation of the German version of the STarT-MSK-Tool: A cohort study with patients from physiotherapy clinics
title Validation of the German version of the STarT-MSK-Tool: A cohort study with patients from physiotherapy clinics
title_full Validation of the German version of the STarT-MSK-Tool: A cohort study with patients from physiotherapy clinics
title_fullStr Validation of the German version of the STarT-MSK-Tool: A cohort study with patients from physiotherapy clinics
title_full_unstemmed Validation of the German version of the STarT-MSK-Tool: A cohort study with patients from physiotherapy clinics
title_short Validation of the German version of the STarT-MSK-Tool: A cohort study with patients from physiotherapy clinics
title_sort validation of the german version of the start-msk-tool: a cohort study with patients from physiotherapy clinics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249194/
https://www.ncbi.nlm.nih.gov/pubmed/35776764
http://dx.doi.org/10.1371/journal.pone.0269694
work_keys_str_mv AT karstenssven validationofthegermanversionofthestartmsktoolacohortstudywithpatientsfromphysiotherapyclinics
AT zebischjochen validationofthegermanversionofthestartmsktoolacohortstudywithpatientsfromphysiotherapyclinics
AT weyjohannes validationofthegermanversionofthestartmsktoolacohortstudywithpatientsfromphysiotherapyclinics
AT hilfikerroger validationofthegermanversionofthestartmsktoolacohortstudywithpatientsfromphysiotherapyclinics
AT hilljonathanc validationofthegermanversionofthestartmsktoolacohortstudywithpatientsfromphysiotherapyclinics